For decades, one of the most significant obstacles to curing pediatric brain tumors has been fragmentation—research happening in isolation, data trapped in silos, and a lack of unified strategy. These diseases are too complex and funding far too limited for stopgap solutions.
At CBTN, we realized it’s time to change the model. CBTN is set up as a research study that follows patients from diagnosis and tracks their progression throughout the treatment journey. This equips us to lead the field with its M3 Approach, a bold, integrated scientific strategy designed to accelerate discovery and bring forward smarter, safer, and more effective treatments for children faster.
